Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model.

Hu J, Schokrpur S, Archang M, Hermann K, Sharrow AC, Khanna P, Novak J, Signoretti S, Bhatt RS, Knudsen BS, Xu H, Wu L.

Mol Ther Methods Clin Dev. 2018 Feb 23;9:203-210. doi: 10.1016/j.omtm.2018.02.009. eCollection 2018 Jun 15.

2.

Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer.

Das L, Gard JMC, Prekeris R, Nagle RB, Morrissey C, Knudsen BS, Miranti CK, Cress AE.

Mol Cancer Res. 2018 May 14. pii: molcanres.0589.2017. doi: 10.1158/1541-7786.MCR-17-0589. [Epub ahead of print]

PMID:
29759989
3.

Regulation of inside-out β1-integrin activation by CDCP1.

Pollan SG, Huang F, Sperger JM, Lang JM, Morrissey C, Cress AE, Chu CY, Bhowmick NA, You S, Freeman MR, Spassov DS, Moasser MM, Carter WG, Satapathy SR, Shah K, Knudsen BS.

Oncogene. 2018 Mar 7. doi: 10.1038/s41388-018-0142-2. [Epub ahead of print]

PMID:
29511352
4.

A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.

Ing N, Huang F, Conley A, You S, Ma Z, Klimov S, Ohe C, Yuan X, Amin MB, Figlin R, Gertych A, Knudsen BS.

Sci Rep. 2017 Oct 16;7(1):13190. doi: 10.1038/s41598-017-13196-4.

5.

Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate.

Ma Z, Shiao SL, Yoshida EJ, Swartwood S, Huang F, Doche ME, Chung AP, Knudsen BS, Gertych A.

Diagn Pathol. 2017 Sep 18;12(1):69. doi: 10.1186/s13000-017-0658-8.

6.

Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model.

Allott EH, Macias E, Sanders S, Knudsen BS, Thomas GV, Hursting SD, Freedland SJ.

Prostate Cancer Prostatic Dis. 2017 Jun;20(2):165-171. doi: 10.1038/pcan.2016.73. Epub 2017 Feb 28.

7.

Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer.

Miller ET, Chamie K, Kwan L, Lewis MS, Knudsen BS, Garraway IP.

Cancer Med. 2017 Jan;6(1):163-172. doi: 10.1002/cam4.981. Epub 2016 Dec 20.

8.

High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients.

Conley A, Minciacchi VR, Lee DH, Knudsen BS, Karlan BY, Citrigno L, Viglietto G, Tewari M, Freeman MR, Demichelis F, Di Vizio D.

RNA Biol. 2017 Mar 4;14(3):305-316. doi: 10.1080/15476286.2016.1259061. Epub 2016 Nov 18.

9.

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

Huang F, Ma Z, Pollan S, Yuan X, Swartwood S, Gertych A, Rodriguez M, Mallick J, Bhele S, Guindi M, Dhall D, Walts AE, Bose S, de Peralta Venturina M, Marchevsky AM, Luthringer DJ, Feller SM, Berman B, Freeman MR, Alvord WG, Vande Woude G, Amin MB, Knudsen BS.

J Pathol Clin Res. 2016 Jul 1;2(4):210-222. eCollection 2016 Oct.

10.

The Cohesive Metastasis Phenotype in Human Prostate Cancer.

Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE.

Biochim Biophys Acta. 2016 Dec;1866(2):221-231. doi: 10.1016/j.bbcan.2016.09.005. Epub 2016 Sep 24. Review.

11.

Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone.

Liu S, Cadaneanu RM, Zhang B, Huo L, Lai K, Li X, Galet C, Grogan TR, Elashoff D, Freedland SJ, Rettig M, Aronson WJ, Knudsen BS, Lewis MS, Garraway IP.

PLoS One. 2016 Oct 6;11(10):e0163232. doi: 10.1371/journal.pone.0163232. eCollection 2016.

12.

A basal cell defect promotes budding of prostatic intraepithelial neoplasia.

Wang M, Nagle RB, Knudsen BS, Rogers GC, Cress AE.

J Cell Sci. 2017 Jan 1;130(1):104-110. doi: 10.1242/jcs.188177. Epub 2016 Sep 8.

13.

Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells.

Das L, Anderson TA, Gard JM, Sroka IC, Strautman SR, Nagle RB, Morrissey C, Knudsen BS, Cress AE.

J Cell Biochem. 2017 May;118(5):1038-1049. doi: 10.1002/jcb.25673. Epub 2017 Jan 5.

14.

Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.

You S, Knudsen BS, Erho N, Alshalalfa M, Takhar M, Al-Deen Ashab H, Davicioni E, Karnes RJ, Klein EA, Den RB, Ross AE, Schaeffer EM, Garraway IP, Kim J, Freeman MR.

Cancer Res. 2016 Sep 1;76(17):4948-58. doi: 10.1158/0008-5472.CAN-16-0902. Epub 2016 Jun 14.

15.

PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance.

Trock BJ, Fedor H, Gurel B, Jenkins RB, Knudsen BS, Fine SW, Said JW, Carter HB, Lotan TL, De Marzo AM.

Mod Pathol. 2016 Jul;29(7):764-71. doi: 10.1038/modpathol.2016.63. Epub 2016 Apr 15.

16.

Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.

Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP.

J Mol Diagn. 2016 May;18(3):395-406. doi: 10.1016/j.jmoldx.2015.12.006. Epub 2016 Mar 3.

17.

Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.

Hahn NM, Knudsen BS, Daneshmand S, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Liu Z, Breen T, Fleming MT, Lance R, Corless CL, Alva AS, Shen SS, Huang F, Gertych A, Gallick GE, Mallick J, Ryan C, Galsky MD, Lerner SP, Posadas EM, Sonpavde G.

Urol Oncol. 2016 Jan;34(1):4.e11-7. doi: 10.1016/j.urolonc.2015.08.005. Epub 2015 Sep 9.

PMID:
26362343
18.

Machine learning approaches to analyze histological images of tissues from radical prostatectomies.

Gertych A, Ing N, Ma Z, Fuchs TJ, Salman S, Mohanty S, Bhele S, Velásquez-Vacca A, Amin MB, Knudsen BS.

Comput Med Imaging Graph. 2015 Dec;46 Pt 2:197-208. doi: 10.1016/j.compmedimag.2015.08.002. Epub 2015 Aug 20.

19.

Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse.

Ogden A, Rida PC, Knudsen BS, Kucuk O, Aneja R.

Cancer Lett. 2015 Oct 28;367(2):89-92. doi: 10.1016/j.canlet.2015.06.025. Epub 2015 Jul 13. Review.

20.

Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanes.

Morley S, You S, Pollan S, Choi J, Zhou B, Hager MH, Steadman K, Spinelli C, Rajendran K, Gertych A, Kim J, Adam RM, Yang W, Krishnan R, Knudsen BS, Di Vizio D, Freeman MR.

Sci Rep. 2015 Jul 16;5:12136. doi: 10.1038/srep12136.

21.

Rapid 3-D delineation of cell nuclei for high-content screening platforms.

Gertych A, Ma Z, Tajbakhsh J, Velásquez-Vacca A, Knudsen BS.

Comput Biol Med. 2016 Feb 1;69:328-38. doi: 10.1016/j.compbiomed.2015.04.025. Epub 2015 Apr 25.

22.

Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma.

Lai JP, Conley A, Knudsen BS, Guindi M.

Histopathology. 2015 Oct;67(4):442-50. doi: 10.1111/his.12623. Epub 2015 Apr 20.

PMID:
25425262
23.

Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.

Gertych A, Mohan S, Maclary S, Mohanty S, Wawrowsky K, Mirocha J, Balzer B, Knudsen BS.

Diagn Pathol. 2014 Nov 25;9:213. doi: 10.1186/s13000-014-0213-9.

24.

Computerized delineation of nuclei in liquid-based pap smears stained with immunohistochemical biomarkers.

Qin Y, Walts AE, Knudsen BS, Gertych A.

Cytometry B Clin Cytom. 2015 Mar;88(2):110-9. doi: 10.1002/cyto.b.21193. Epub 2014 Oct 3.

25.

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.

Cheng HH, Mitchell PS, Kroh EM, Dowell AE, Chéry L, Siddiqui J, Nelson PS, Vessella RL, Knudsen BS, Chinnaiyan AM, Pienta KJ, Morrissey C, Tewari M.

PLoS One. 2013 Jul 30;8(7):e69239. doi: 10.1371/journal.pone.0069239. Print 2013.

26.

Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases.

Akfirat C, Zhang X, Ventura A, Berel D, Colangelo ME, Miranti CK, Krajewska M, Reed JC, Higano CS, True LD, Vessella RL, Morrissey C, Knudsen BS.

J Pathol. 2013 Jul;230(3):291-7. doi: 10.1002/path.4180.

27.

Statistical Methods for Tissue Array Images - Algorithmic Scoring and Co-training.

Yan D, Wang P, Knudsen BS, Linden M, Randolph TW.

Ann Appl Stat. 2012 Sep;6(3):1280-1305.

28.

Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.

FitzGerald LM, Zhang X, Kolb S, Kwon EM, Liew YC, Hurtado-Coll A, Knudsen BS, Ostrander EA, Stanford JL.

Hum Mutat. 2013 Jan;34(1):149-56. doi: 10.1002/humu.22176. Epub 2012 Oct 4.

29.

Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

Putzke AP, Ventura AP, Bailey AM, Akture C, Opoku-Ansah J, Celiktaş M, Hwang MS, Darling DS, Coleman IM, Nelson PS, Nguyen HM, Corey E, Tewari M, Morrissey C, Vessella RL, Knudsen BS.

Am J Pathol. 2011 Jul;179(1):400-10. doi: 10.1016/j.ajpath.2011.03.028. Epub 2011 May 4.

30.

Mechanisms of prostate cancer initiation and progression.

Knudsen BS, Vasioukhin V.

Adv Cancer Res. 2010;109:1-50. doi: 10.1016/B978-0-12-380890-5.00001-6. Review.

PMID:
21070913
31.

Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.

Risk MC, Knudsen BS, Coleman I, Dumpit RF, Kristal AR, LeMeur N, Gentleman RC, True LD, Nelson PS, Lin DW.

Clin Cancer Res. 2010 Nov 15;16(22):5414-23. doi: 10.1158/1078-0432.CCR-10-0272. Epub 2010 Oct 8.

32.

Activation of the MEK-S6 pathway in high-grade ovarian cancers.

Ventura AP, Radhakrishnan S, Green A, Rajaram SK, Allen AN, O'Briant K, Schummer M, Karlan B, Urban N, Tewari M, Drescher C, Knudsen BS.

Appl Immunohistochem Mol Morphol. 2010 Dec;18(6):499-508. doi: 10.1097/PAI.0b013e3181e53e1c.

33.

DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.

Houshdaran S, Hawley S, Palmer C, Campan M, Olsen MN, Ventura AP, Knudsen BS, Drescher CW, Urban ND, Brown PO, Laird PW.

PLoS One. 2010 Feb 22;5(2):e9359. doi: 10.1371/journal.pone.0009359.

34.
35.

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.

Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY, Drescher CW, Urban N, Knudsen BS, Tewari M.

Gynecol Oncol. 2010 Jan;116(1):117-25. doi: 10.1016/j.ygyno.2009.08.009. Epub 2009 Oct 24.

36.

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS, Tewari M.

PLoS One. 2009;4(4):e5311. doi: 10.1371/journal.pone.0005311. Epub 2009 Apr 23.

37.

Spectral analysis of multiplex Raman probe signatures.

Lutz BR, Dentinger CE, Nguyen LN, Sun L, Zhang J, Allen AN, Chan S, Knudsen BS.

ACS Nano. 2008 Nov 25;2(11):2306-14. doi: 10.1021/nn800243g.

38.

A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.

Knudsen BS, Zhao P, Resau J, Cottingham S, Gherardi E, Xu E, Berghuis B, Daugherty J, Grabinski T, Toro J, Giambernardi T, Skinner RS, Gross M, Hudson E, Kort E, Lengyel E, Ventura A, West RA, Xie Q, Hay R, Vande Woude G, Cao B.

Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):57-67. doi: 10.1097/PAI.0b013e3181816ae2.

39.

Circulating microRNAs as stable blood-based markers for cancer detection.

Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M.

Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8. doi: 10.1073/pnas.0804549105. Epub 2008 Jul 28.

40.

Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.

Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC, Drescher CW, Schummer M, McIntosh MW, Knudsen BS, Hanash SM.

PLoS One. 2008 Jun 18;3(6):e2425. doi: 10.1371/journal.pone.0002425.

41.

Showering c-MET-dependent cancers with drugs.

Knudsen BS, Vande Woude G.

Curr Opin Genet Dev. 2008 Feb;18(1):87-96. doi: 10.1016/j.gde.2008.02.001. Epub 2008 Apr 9. Review.

PMID:
18406132
42.

Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues.

Knudsen BS, Allen AN, McLerran DF, Vessella RL, Karademos J, Davies JE, Maqsodi B, McMaster GK, Kristal AR.

J Mol Diagn. 2008 Mar;10(2):169-76. doi: 10.2353/jmoldx.2008.070127. Epub 2008 Feb 14.

43.

Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissues.

Lin DW, Neuhouser ML, Schenk JM, Coleman IM, Hawley S, Gifford D, Hung H, Knudsen BS, Nelson PS, Kristal AR.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2150-4.

44.

Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression.

Xu C, Graf LF, Fazli L, Coleman IM, Mauldin DE, Li D, Nelson PS, Gleave M, Plymate SR, Cox ME, Torok-Storb BJ, Knudsen BS.

Prostate. 2007 Nov 1;67(15):1621-9.

PMID:
17823924
45.
46.

A working group classification of focal prostate atrophy lesions.

De Marzo AM, Platz EA, Epstein JI, Ali T, Billis A, Chan TY, Cheng L, Datta M, Egevad L, Ertoy-Baydar D, Farre X, Fine SW, Iczkowski KA, Ittmann M, Knudsen BS, Loda M, Lopez-Beltran A, Magi-Galluzzi C, Mikuz G, Montironi R, Pikarsky E, Pizov G, Rubin MA, Samaratunga H, Sebo T, Sesterhenn IA, Shah RB, Signoretti S, Simko J, Thomas G, Troncoso P, Tsuzuki TT, van Leenders GJ, Yang XJ, Zhou M, Figg WD, Hoque A, Lucia MS.

Am J Surg Pathol. 2006 Oct;30(10):1281-91. Erratum in: Am J Surg Pathol. 2006 Nov;30(11):1489. Farree, Xavier [corrected to Farre, Xavier]. Am J Surg Pathol. 2007 Apr;31(4):652. Shah, Rajiv B [corrected to Shah, Rajal B]; Hoque, Ashrafal [corrected to Hoque, Ashraful].

PMID:
17001160
47.

Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis.

Lin DW, Coleman IM, Hawley S, Huang CY, Dumpit R, Gifford D, Kezele P, Hung H, Knudsen BS, Kristal AR, Nelson PS.

J Clin Oncol. 2006 Aug 10;24(23):3763-70. Epub 2006 Jul 5. Erratum in: J Clin Oncol. 2007 Jun 1;25(16):2334. Huang, Chung Y [added].

PMID:
16822846
48.
49.

Regulation of cell proliferation in a stratified culture system of epithelial cells from prostate tissue.

Gustafson MP, Xu C, Grim JE, Clurman BE, Knudsen BS.

Cell Tissue Res. 2006 Aug;325(2):263-76. Epub 2006 Mar 24.

PMID:
16557385
50.

Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek).

Hay RV, Cao B, Skinner RS, Su Y, Zhao P, Gustafson MF, Qian CN, Teh BT, Knudsen BS, Resau JH, Shen S, Waters DJ, Gross MD, Vande Woude GF.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7064s-7069s.

Supplemental Content

Loading ...
Support Center